Ferring Collaborates with Chinese Academy of Science on Women's Health

Ferring Pharma, a Swiss company with a focus on reproductive medicine and women’s health, formed a long-term collaboration with the Chinese Academy of Sciences (CAS). As part of the effort, Ferring and CAS established a jointly funded laboratory in a Beijing CAS research facility. It will house Ferring and CAS researchers who will address unmet needs in fertility and high rates of obstetric complications. The two entities plan to develop basic and translational research in reproductive medicine, developing novel products and new therapies. More details.... Share this with colleagues: // //